BACKGROUND. Indirect-immunofluorescence studies of skin and cultured dermal fibroblasts from patients with the Marfan syndrome demonstrate apparent deficiency of one element of connective tissue--the microfibrillar-fiber system--in assays using specific antibodies against fibrillin, a major microfibrillar protein. This study was designed to test whether these immunostaining abnormalities are consistent and diagnostic features of the disease. METHODS. We studied patients with either the Marfan syndrome or various other inherited connective-tissue disorders and normal subjects according to a single-blind protocol in which coded samples of skin, fibroblast cultures, or both were analyzed without knowledge of the clinical diagnosis and classified as "Marfan" or "non-Marfan" before the sample codes were broken. RESULTS. Of the 27 patients with the Marfan syndrome, 24 were correctly identified by the decreased content of microfibrillar fibers in their skin, cultured fibroblasts, or both; in contrast, 19 of 25 patients with other heritable disorders of connective tissue and all 13 normal subjects were correctly classified as "non-Marfan" by these assays (P less than 0.001). CONCLUSIONS. These results document consistent, relatively specific abnormalities of microfibrillar fibers in the Marfan syndrome. The biomechanical incompetence of these structural elements, due to quantitative or qualitative abnormalities, may account for the pleiotropic clinical manifestations of the disease. Therefore, various defects in the expression, structure, assembly, or degradation of the constituent structural glycoprotein (or glycoproteins) of microfibrils may be implicated in the causation of the Marfan syndrome.
Source Information
Portland Unit, Shriners Hospitals for Crippled Children.
This article has been cited by other articles:
Sengle, G., Charbonneau, N. L., Ono, R. N., Sasaki, T., Alvarez, J., Keene, D. R., Bachinger, H. P., Sakai, L. Y.
(2008). Targeting of Bone Morphogenetic Protein Growth Factor Complexes to Fibrillin. J. Biol. Chem.
283: 13874-13888
[Abstract][Full Text]
Kuo, C.-L., Isogai, Z., Keene, D. R., Hazeki, N., Ono, R. N., Sengle, G., Peter Bachinger, H., Sakai, L. Y.
(2007). Effects of Fibrillin-1 Degradation on Microfibril Ultrastructure. J. Biol. Chem.
282: 4007-4020
[Abstract][Full Text]
Robinson, P N, Arteaga-Solis, E, Baldock, C, Collod-Beroud, G, Booms, P, De Paepe, A, Dietz, H C, Guo, G, Handford, P A, Judge, D P, Kielty, C M, Loeys, B, Milewicz, D M, Ney, A, Ramirez, F, Reinhardt, D P, Tiedemann, K, Whiteman, P, Godfrey, M
(2006). The molecular genetics of Marfan syndrome and related disorders. J. Med. Genet.
43: 769-787
[Abstract][Full Text]
Ganesh, A., Smith, C., Chan, W., Unger, S., Quercia, N., Godfrey, M., Kraft, S., Buncic, R., Levin, A.
(2006). Immunohistochemical evaluation of conjunctival fibrillin-1 in Marfan syndrome.. Arch Ophthalmol
124: 205-209
[Abstract][Full Text]
(2005). Picture of the Month--Diagnosis. Arch Pediatr Adolesc Med
159: 722-723
[Full Text]
Nataatmadja, M., West, M., West, J., Summers, K., Walker, P., Nagata, M., Watanabe, T.
(2003). Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm. Circulation
108: II-329-334
[Abstract][Full Text]
Charbonneau, N. L., Dzamba, B. J., Ono, R. N., Keene, D. R., Corson, G. M., Reinhardt, D. P., Sakai, L. Y.
(2003). Fibrillins Can Co-assemble in Fibrils, but Fibrillin Fibril Composition Displays Cell-specific Differences. J. Biol. Chem.
278: 2740-2749
[Abstract][Full Text]
Isogai, Z., Ono, R. N., Ushiro, S., Keene, D. R., Chen, Y., Mazzieri, R., Charbonneau, N. L., Reinhardt, D. P., Rifkin, D. B., Sakai, L. Y.
(2003). Latent Transforming Growth Factor beta -binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein. J. Biol. Chem.
278: 2750-2757
[Abstract][Full Text]
Lin, G., Tiedemann, K., Vollbrandt, T., Peters, H., Batge, B., Brinckmann, J., Reinhardt, D. P.
(2002). Homo- and Heterotypic Fibrillin-1 and -2 Interactions Constitute the Basis for the Assembly of Microfibrils. J. Biol. Chem.
277: 50795-50804
[Abstract][Full Text]
Wityk, R. J., Zanferrari, C., Oppenheimer, S.
(2002). Neurovascular Complications of Marfan Syndrome: A Retrospective, Hospital-Based Study. Stroke
33: 680-684
[Abstract][Full Text]
Robinson, P. N, Godfrey, M.
(2000). The molecular genetics of Marfan syndrome and related microfibrillopathies. J. Med. Genet.
37: 9-25
[Abstract][Full Text]
Westaby, S.
(1999). Aortic dissection in Marfan's syndrome. Ann. Thorac. Surg.
67: 1861-1863
[Abstract][Full Text]
Zhang, M.-C., He, L., Giro, M., Yong, S. L., Tiller, G. E., Davidson, J. M.
(1999). Cutis Laxa Arising from Frameshift Mutations in Exon 30 of the Elastin Gene (ELN). J. Biol. Chem.
274: 981-986
[Abstract][Full Text]
Rodeo, S. A., Suzuki, K., Yamauchi, M., Bhargava, M., Warren, R. F.
(1998). Analysis of Collagen and Elastic Fibers in Shoulder Capsule in Patients with Shoulder Instability. Am J Sports Med
26: 634-643
[Abstract][Full Text]
Fleischer, K. J., Nousari, H. C., Anhalt, G. J., Stone, C. D., Laschinger, J. C.
(1997). Immunohistochemical Abnormalities of Fibrillin in Cardiovascular Tissues in Marfan's Syndrome. Ann. Thorac. Surg.
63: 1012-1017
[Abstract][Full Text]
Lipscomb, K. J, Clayton-Smith, J., Harris, R.
(1997). Evolving phenotype of Marfan's syndrome. Arch. Dis. Child.
76: 41-46
[Abstract][Full Text]
Payne, R. M., Johnson, M. C., Grant, J. W., Strauss, A. W.
(1995). Toward a Molecular Understanding of Congenital Heart Disease. Circulation
91: 494-504
[Abstract][Full Text]
Tiedemann, K., Batge, B., Muller, P. K., Reinhardt, D. P.
(2001). Interactions of Fibrillin-1 with Heparin/Heparan Sulfate, Implications for Microfibrillar Assembly. J. Biol. Chem.
276: 36035-36042
[Abstract][Full Text]
Previous
